Whilst a good announcement,not what we need to really kick the sp along.Still no US funds buying in,is a bit concerning,as we were told that was the reason for the consildation.
Ann: Neuren's Rett syndrome Phase 2 trial published in Neurology, page-7
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$13.04 |
Change
0.185(1.44%) |
Mkt cap ! $1.626B | |||
| Open | High | Low | Value | Volume |
| $13.15 | $13.37 | $12.92 | $5.849M | 446.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 22 | 1272 | $13.03 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.04 | 124 | 3 |
View Market Depth
| Last trade - 15.13pm 18/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |